Individualized Treatment for TMJ Dysfunction

(TMD3c Trial)

Overseen By Elise Kabela-Cormier, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: UConn Health

Must not be taking: Narcotic pain medication

Disqualifiers: Psychosis, Neuropathic pain, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 7

Duration: 6 weeks

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to find the best way to ease jaw pain from temporomandibular disorders (TMD) using personalized treatment plans. Researchers compare two approaches: a new, highly tailored coping skills training called the Individualized Assessment and Treatment Program (IATP) and a more traditional cognitive-behavioral therapy, both alongside standard dental care. People experiencing jaw pain for more than three months and with a confirmed TMD diagnosis may be a good fit. The goal is to determine if the personalized approach can more effectively reduce pain, depression, and daily life disruptions.

As an unphased trial, this study offers participants the chance to contribute to innovative research that could lead to more effective treatments for TMD.

Will I have to stop taking my current medications?

The trial requires that you do not take narcotic pain medication. If you are currently taking narcotics for pain, you would need to stop before participating.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

In a previous study, patients who received cognitive-behavioral treatment (CBT) for temporomandibular disorder (TMD) experienced less pain and felt better overall. No major safety issues were reported, indicating that CBT is generally safe for this condition.

Specific safety data for the Individualized Assessment and Treatment Program (IATP) for TMD is not yet available. However, as this study is in its early stages and focuses on tailoring treatment to each patient's needs, it suggests a careful approach. This likely involves closely monitoring patient reactions to the treatment.

Overall, both treatment options in this study seem to prioritize patient safety, with no reports of serious side effects. For any concerns, discussing them with the researchers or a healthcare provider before joining the trial is advisable. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the Individualized Assessment and Treatment Program (IATP) for TMJ dysfunction because it offers a highly personalized approach to managing pain. Unlike standard treatments that typically focus on general conservative dental care, this program integrates individualized coping skills training tailored to each patient's specific needs. This personalized strategy aims to enhance the effectiveness of pain management by addressing the unique psychological and behavioral factors contributing to each patient's condition. By combining standard care with this customized approach, there is potential for improved outcomes and a better quality of life for those suffering from TMJ dysfunction.

What evidence suggests that this trial's treatments could be effective for TMD?

Research has shown that cognitive-behavioral therapy (CBT), one of the treatments in this trial, can reduce pain and emotional issues in people with temporomandibular disorders (TMD). Studies have found that CBT not only eases pain but also lessens the impact of TMD on daily life and reduces symptoms of depression. Meanwhile, the Individualized Assessment and Treatment Program (IATP), another treatment option in this trial, aims to be even more effective by customizing treatment for each person. Early results suggest that IATP might lower pain, depression, and daily life disruption more than standard treatments. This approach focuses on improving coping skills, which could be important for managing long-term pain. ^{1 6 7 8 9}

Who Is on the Research Team?

Mark D Litt, Ph.D.

Principal Investigator

UConn Health

Are You a Good Fit for This Trial?

This trial is for adults over 18 living in the Greater Hartford, CT area with facial pain or TMJ disorders. Participants must have a confirmed diagnosis of TMD and experience jaw pain for more than three months. It's not open to those on narcotic pain meds, with previous TMD surgery, severe TM joint damage, non-English speakers, neuropathic/odontogenic pain origins, certain comorbid conditions or current depression treatment.

Inclusion Criteria

I have been diagnosed with a muscle or fascia condition.

I have been diagnosed with muscle pain, joint pain, or TMJ-related headaches.

You live in the Greater Hartford. CT area

Exclusion Criteria

I have been diagnosed with nerve or tooth-related pain.

You have been diagnosed with a mental illness called psychosis.

I use a device in my mouth for a health condition like sleep apnea.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-treatment Monitoring

Experience Sampling (ES) procedure conducted via smartphone app to gather information on patients' pain, momentary cognitions, affects, and coping behaviors

2 weeks

Remote monitoring

Treatment

Participants receive either STD+IATP or STD+CBT treatment, including 6 sessions of cognitive-behavioral coping skills training

6 weeks

Follow-up

Participants are monitored for changes in depressive symptoms, pain, interference, and coping ability at multiple follow-up points

12 months

Follow-up assessments at 7 weeks, 3 months, 6 months, 9 months, and 12 months

What Are the Treatments Tested in This Trial?

Interventions

• Cognitive-Behavioral Treatment
• Individualized Assessment and Treatment Program
• Standard Conservative Care

Trial Overview

The study compares two treatments for TMD: an individualized assessment and treatment program (IATP) added to standard care versus standard care plus conventional cognitive-behavioral therapy (CBT). The goal is to see if IATP leads to better outcomes in reducing pain and improving coping skills compared to CBT.

How Is the Trial Designed?

Group I: STD+IATP Experimental Treatment 2 Interventions

Standard conservative dental orofacial pain care + Individualized Assessment and Treatment Program; a highly individualized coping skills training procedure.

Group II: STD+CBT Active Control 2 Interventions

Standard conservative dental orofacial pain care + cognitive-behavioral coping skills treatment

Who Is Running the Clinical Trial?

UConn Health

Lead Sponsor

Trials

218

Recruited

59,100+

National Institute of Dental and Craniofacial Research (NIDCR)

Collaborator

Trials

312

Recruited

853,000+

Published Research Related to This Trial

The Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) has been developed to provide a reliable classification system for TMDs, incorporating a biopsychosocial model and demonstrating strong sensitivity and specificity for pain-related disorders.

The DC/TMD has been successfully integrated into the AAPT framework, which offers a structured approach for diagnosing and understanding TMDs and their comorbidities, paving the way for future research on orofacial pain conditions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

AAPT Diagnostic Criteria for Chronic Painful Temporomandibular Disorders. Ohrbach, R., Dworkin, SF.[2020]

In a large-scale study involving over 6,500 patients, those who received treatment for temporomandibular disorders (TMD) showed significant symptom improvement compared to untreated patients, who reported no changes.

The study utilized a validated symptom measurement system, the TMJ Scale, to ensure consistent assessment of treatment outcomes, reinforcing the conclusion that TMD does not improve spontaneously without intervention.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Temporomandibular disorder treatment outcomes: first report of a large-scale prospective clinical study. Gaudet, EL., Brown, DT.[2019]

A Delphi survey involving 23 international experts identified four key questionnaires and three pain screening tools as the most clinically useful for assessing temporomandibular disorders (TMD), emphasizing their reliability and validity.

The survey also highlighted eight essential physical examination tests, which can help clinicians effectively evaluate TMD, aligning with established diagnostic criteria and potentially guiding future research and policy decisions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

International consensus on the most useful assessments used by physical therapists to evaluate patients with temporomandibular disorders: A Delphi study. von Piekartz, H., Schwiddessen, J., Reineke, L., et al.[2020]

Out of 1297 patients with temporomandibular disorders, 88% reported a significant improvement (50% or more) in their symptoms after treatment, indicating high efficacy of the treatment approach.

The ability to predict treatment outcomes was strong, with 90% of patients with muscular symptoms and 94% of those with TMJ symptoms achieving positive results when a good outcome was anticipated.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Individual prediction of treatment outcome in patients with temporomandibular disorders. Sundqvist, B., Magnusson, T.[2006]

Physical therapy is essential in managing temporomandibular joint dysfunction (TMJD), particularly for treating stiffness following trauma.

Combining TMJ strapping with conventional physical therapy can effectively reduce clicking sounds, alleviate pain, and enhance jaw function in patients with TMJD.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Strapping for temporomandibular joint dysfunction. Babu, AS., John, SM., Unni, A.[2019]

In a study of 52 patients with temporomandibular disorders (TMDs), there was a significant discrepancy between doctors' and patients' assessments of treatment outcomes, with 44% of cases showing differing evaluations.

Doctors tended to rate patient improvement more positively than patients did, indicating that relying solely on physician assessments may not accurately reflect patient experiences and treatment effectiveness.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Global doctor opinion versus a patient questionnaire for the outcome assessment of treated temporomandibular disorder patients. Ness, GM., Laskin, DM.[2019]

In a long-term study involving 2104 treated and 250 untreated TMD patients, it was found that untreated TMD patients do not improve on their own, highlighting the necessity of treatment.

Patients who received various active treatments showed significant improvement without relapse, with anterior repositioning appliance therapy proving more effective than flat plane splint therapy.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Temporomandibular disorder treatment outcomes: second report of a large-scale prospective clinical study. Brown, DT., Gaudet, EL.[2019]

A study involving 145 patients with temporomandibular disorders (TMD) revealed significant variability in diagnosis and treatment approaches between two clinics, including differences in the use of imaging and treatment types.

Despite these differences in clinical practices, there were no significant variations in patient-reported pain and dysfunction after one year, highlighting the need for standardized treatment protocols in TMD management.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Temporomandibular disorders. Variation in clinical practice. Von Korff, MR., Howard, JA., Truelove, EL., et al.[2019]

A TMD-trained general dental practitioner was able to predict treatment outcomes for patients with temporomandibular disorders (TMD) with similar accuracy to a TMD specialist, achieving 100% improvement in patients predicted to have a 'Good' outcome.

In a comparison of treatment outcomes, the general dental practitioner showed high success rates (100% for Muscle symptoms and 100% for Mainly TMJ symptoms) in accurately predicting improvements, suggesting that training can enhance the effectiveness of general practitioners in managing TMD.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Comparison of individual prediction of treatment outcome made by a TMD specialist and a TMD-trained general dental practitioner in patients with temporomandibular disorders. Sundqvist, B., Wenneberg, B., Magnusson, T.[2019]

A study involving 2,187 patients with temporomandibular disorders (TMD) showed that continuous quality improvement in clinical routines significantly enhanced the prediction of treatment outcomes, with 90% of patients predicted to have a good outcome achieving a clinically important difference in symptom improvement.

In both patient groups (Muscle and Mainly TMJ symptoms), a high percentage of those predicted to have good outcomes reached significant symptom improvement, indicating that the prediction model was effective, and rheumatic disease did not negatively impact treatment success.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Validation and improvement of a predictive model for treatment outcome in patients with temporomandibular disorders. Sundqvist, B., Wenneberg, B., Magnusson, T.[2019]

The one-page screening process for temporomandibular disorders (TMD) is efficient and user-friendly, making it easy to implement in dental practices.

While the screening process is effective, it is essential to follow up with a thorough history review and clinical examination to ensure accurate diagnosis and appropriate treatment for the diverse range of TMDs.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Temporomandibular disorders: a practical screening process. Kinderknecht, KE., Thomas, CA.[2015]

A review of 90 randomized clinical trials on treatments for temporomandibular disorders (TMDs) revealed that the quality of reporting on statistical methods and adverse events was generally poor, impacting the assessment of risk-to-benefit ratios.

While there was some improvement in reporting practices in newer studies (2006-2013) compared to older ones (1971-2005), critical details such as primary outcome analyses and methods for handling missing data were still inadequately reported, highlighting a need for better standards in clinical trial reporting.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Reporting of adverse events and statistical details of efficacy estimates in randomized clinical trials of pain in temporomandibular disorders: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review. Gewandter, JS., Smith, SM., McKeown, A., et al.[2018]

Citations

1.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC2939176/

Brief Cognitive-Behavioral Treatment for TMD Pain

It was concluded that brief treatments can yield significant reductions in pain, life interference and depressive symptoms in TMD sufferers.

2.

tandfonline.com

tandfonline.com/doi/full/10.1080/19424396.2025.2474834

Effectiveness of Cognitive Behavioral Therapy in Managing ...

CBT was found to be beneficial in reducing pain and psychological impairment in TMD patients. This improved masticatory jaw use limitations, pain beliefs, ...

3.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11934845/

Comparative evaluation of cognitive behavioural therapy ...

This systematic review highlights the potential benefits of CBT in managing TMDs, suggesting its effectiveness in improving pain outcomes and enhancing overall ...

4.

sciencedirect.com

sciencedirect.com/science/article/pii/S1882761625000171

The effectiveness of mobilization in treating patients with ...

The evidence shows improvements in pain intensity, range of motion, and other patient-reported outcomes, following TMJ mobilization. These effects were observed ...

5.

journals.lww.com

journals.lww.com/aomr/fulltext/2023/35030/psychological_assessment_and_cognitive_behavioral.8.aspx

Psychological Assessment and Cognitive Behavioral ...

The results of this study demonstrate the effectiveness of CBT as a psychological intervention for TMD patients. In this study, the effectiveness of CBT was ...

6.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC10218610/

Evaluation of Clinical Symptoms Improvement by Cognitive ...

Temporomandibular disorder (TMD) fundamentally requires cognitive behavioral therapy (CBT), including physical self-regulation.

7.

clinicaltrials.gov

clinicaltrials.gov/study/NCT00769561

Biofeedback-Based Cognitive Behavioral Treatment for ...

The purpose of this study is to develop and evaluate a biofeedback-based cognitive behavioral treatment for temporomandibular disorders using a randomized ...

8.

aafp.org

aafp.org/pubs/afp/issues/2023/0100/temporomandibular-disorders.html

Temporomandibular Disorders: Rapid Evidence Review

There is insufficient evidence to support the use of psychological therapy (e.g., cognitive behavior therapy, behavior therapy, acceptance and commitment ...

9.

sciencedirect.com

sciencedirect.com/science/article/abs/pii/S030439590500326X

Effects on daily electronic outcome and process measures

The brief CB treatment was efficacious in decreasing catastrophizing and increasing perceived control over pain, and in improving activity interference and jaw ...